1-2 of 2
Brock Martin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase I clinical trial adding OX40 agonism to in situ therapeutic cancer vaccination in patients with low-grade B cell lymphoma highlights challenges in translation from mouse to human studies

Tanaya Shree, Debra Czerwinski, Sarah Haebe, Anuja Sathe, Sue Grimes, Brock Martin, Michael Ozawa, Richard Hoppe, Hanlee Ji, Ronald Levy
Journal: Clinical Cancer Research
Clin Cancer Res (2025)
https://doi.org/10.1158/1078-0432.CCR-24-2770
Published: 02 January 2025
View article titled, A phase I clinical trial adding OX40 agonism to in situ therapeutic cancer vaccination in patients with low-grade B cell lymphoma highlights challenges in translation from mouse to human studies
Open the PDF for A phase I clinical trial adding OX40 agonism to in situ therapeutic cancer vaccination in patients with low-grade B cell lymphoma highlights challenges in translation from mouse to human studies in another window
Includes: Supplementary data
Journal Articles

The Sentinel Margin: Intraoperative Ex Vivo Specimen Mapping Using Relative Fluorescence Intensity

Stan van Keulen, Naoki Nishio, Andrew Birkeland, Shayan Fakurnejad, Brock Martin, Tim Forouzanfar, Kristen Cunanan, A. Dimitrios Colevas, Nynke S. van den Berg, Eben Rosenthal
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (15): 4656–4662.
https://doi.org/10.1158/1078-0432.CCR-19-0319
Published: 01 August 2019
View article titled, The Sentinel Margin: Intraoperative <em>Ex Vivo</em> Specimen Mapping Using Relative Fluorescence Intensity
Open the PDF for The Sentinel Margin: Intraoperative <em>Ex Vivo</em> Specimen Mapping Using Relative Fluorescence Intensity in another window
Includes: Supplementary data